truebinding.comHealthcare / Healthcare softwareFounded: 2016Funding to Date: $175.12MM
TrueBinding is an antibody therapeutics company that works to create new clinical molecule applications. With a mission to treat health concerns such as neurodegenerative and metabolic diseases, the biotechnology research company uses big data and artificial intelligence to provide targeted immunotherapy for patients. TrueBinding was founded by Dongxu Sun in 2015 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/17/2023 | Series D | $13.45MM | $xx.xx | $1.21B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,440,010
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/17/2023 | Series D-1 | $53.31MM | $xx.xx | $1.21B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
10,484,699
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/08/2022 | Series C | $100MM | $xx.xx | $372.51MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
73,260,072
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/10/2019 | Series B | $5.37MM | $xx.xx | $108.9MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,899,944
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/30/2017 | Series A | $3MM | $xx.xx | $15MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
30,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|